LIPID TRENDS ON DONOR DERIVED ATHEROSCLEROTIC DISEASE AND ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS AT A LARGE ACADEMIC CENTER

LIPID TRENDS ON DONOR DERIVED ATHEROSCLEROTIC DISEASE AND ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS AT A LARGE ACADEMIC CENTER

Therapeutic Area: ASCVD/CVD in Special Populations Background: Prior studies demonstrate an association between statins and reduction in mortality and incidence of coronary allograft vasculopathy (CAV) following heart transplant, and while lipid lowering with LDL < 100 mg/dL is associated with re...

Full description

Bibliographic Details
Main Authors:	Antoinette S. Birs, MD, Eric D. Adler, MD, Pam R. Taub, MD, Michael Wilkinson, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	American Journal of Preventive Cardiology
Online Access:	http://www.sciencedirect.com/science/article/pii/S266666772300082X

Similar Items

Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy
by: Giovanni Civieri, MD, et al.
Published: (2023-05-01)

Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation
by: Natasha Aleksova, MD, et al.
Published: (2021-12-01)

Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.
by: Carlos A Labarrere, et al.
Published: (2014-01-01)

Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
by: Anu K. Kaskinen, MD, PhD, et al.
Published: (2023-10-01)

Postsurgical skin ulcers caused by cytomegalovirus vasculopathy in a renal transplant recipient
by: Shikha Rao, MD, et al.
Published: (2020-07-01)

Inpatient Kidney Palliative Care for Kidney Transplant Recipients With Failing Allografts
by: Naoka Murakami, MD, PhD, et al.
Published: (2022-02-01)

Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
by: Erbin Dai, et al.
Published: (2010-05-01)

Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
by: Bibhuti B. Das, et al.
Published: (2022-07-01)

ONE YEAR EXPERIENCE WITH INCLISIRAN IN AN ACADEMIC LIPID CLINIC:
by: Tommy T. Chiou, BA, et al.
Published: (2023-09-01)

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy
by: Milena A. Gebska, MD, PhD, et al.
Published: (2020-02-01)

Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
by: Annika Gocht, et al.
Published: (2018-07-01)

Influence of Donor Race and Donor-recipient Race-matching on Pediatric Kidney Transplant Outcomes
by: Kennedy Sun, et al.
Published: (2022-06-01)

Factors associated with cardiac allograft vasculopathy after heart transplantation
by: Wioletta Szczurek-Wasilewicz, et al.
Published: (2022-10-01)

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
by: Yi-Wen Lin, et al.
Published: (2022-05-01)

Predictors of allograft survival and patient survival in living donor renal transplant recipients
by: Pinaki Mukhopadhyay, et al.
Published: (2017-01-01)

Usefulness of left ventricular peak filling rate measurement by cardiac MR imaging in heart transplant recipients with cardiac allograft vasculopathy
by: Kojima Shinya, et al.
Published: (2010-01-01)

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
by: Laila Lakhani, MD, et al.
Published: (2021-02-01)

Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants
by: Janina Müller-Deile, MD, et al.
Published: (2017-10-01)

Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
by: Zhenggang Zhang, et al.
Published: (2021-03-01)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
by: Amanda Jean Vinson, MD, et al.
Published: (2019-01-01)

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
by: Ute Eisenberger, MD, et al.
Published: (2019-01-01)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
by: Hajime Imamura, MD, et al.
Published: (2017-07-01)

Osteochondral Allograft and Concurrent Meniscal Allograft Transplantation
by: Hansel E. Ihn MD, et al.
Published: (2023-07-01)

Generation of donor-specific immunotolerance in renal-allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

Outcomes in Adult Liver Transplant Recipients Using Pediatric Deceased Donor Liver Grafts
by: Paola A. Vargas, MD, et al.
Published: (2022-05-01)

Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
by: Fernando Bacal, et al.
Published: (2000-11-01)

Osteochondral Allograft Transplantation
by: John W. Belk BA, et al.
Published: (2023-01-01)

Donor-derived Cell-free DNA in Infections in Kidney Transplant Recipients: Case Series
by: Naeem Goussous, MD, et al.
Published: (2020-07-01)

Abstract: Transplanted Fat Adapts to the Environment of the Recipient: A Study to Investigate the Suitability of Donor Recipient Obesity Mismatch in Face Transplantation
by: Marissa Suchyta, BA, et al.
Published: (2018-09-01)

Osteochondral Allograft Transplantation of the Medial Femoral Condyle With Orthobiologic Augmentation and Graft-Recipient Microfracture Preparation
by: James Gwosdz, M.D., et al.
Published: (2019-03-01)

Meniscal Allograft Transplantation With Concomitant Osteochondral Allograft Transplantation
by: Eric J. Cotter, B.S., et al.
Published: (2017-10-01)

Atrial arrhythmia in a patient after bicaval heart transplantation: Evidence for recipient-to-donor conduction
by: Ahmad Hayek, MD, et al.
Published: (2020-01-01)

Cardiac allograft vasculopathy: How can it be predicted?
by: Rita Calé, et al.
Published: (2020-04-01)

Impact of the Mayo Adhesive Probability Score on Donor and Recipient Outcomes After Living-donor Kidney Transplantation: A Retrospective, Single-center Study of 782 Transplants
by: Yu Sato, MD, et al.
Published: (2021-08-01)

Screening of cardiac allograft vasculopathy in heart transplant patients with coronary computed tomography angiography
by: Ana Filipa Amador, et al.
Published: (2024-02-01)

Resistant cytomegalovirus infection in related donor kidney allograft recipients
by: V A Goryainov, et al.
Published: (2016-06-01)

Characteristics and prognosis of lymphoproliferative disorders post-renal transplantation in living versus deceased donor allograft recipients
by: Hossein Khedmat, et al.
Published: (2013-01-01)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
by: David A. Axelrod, MD, MBA, et al.
Published: (2020-12-01)

Donor–Recipient BSA Matching Is Prognostically Significant in Solitary and En Bloc Kidney Transplantation From Pediatric Circulatory Death Donors
by: Christopher J. Little, MD, et al.
Published: (2021-08-01)

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission
by: Robert A. Mitchell, MD, et al.
Published: (2018-03-01)